Five systemic drugs, including fingolimod and apixaban, were identified with under-recognized maculopathy risks using ...
Neda Shamie, MD, recounts a humbling experience performing cataract surgery in Honduras using older-generation phaco machines ...
Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...
The FDA issued a complete response letter for SYD-101, citing insufficient evidence of effectiveness despite achieving ...
Broadwood Partners, STAAR's largest shareholder, opposes the Alcon merger, citing board conflicts and rushed decision-making.
Nanoscope Therapeutics has released positive 3-year follow-up data from its REMAIN study, the long-term extension of the ...
Glaukos recently obtained FDA clearance for Epioxa, a topical, incision-free therapy for keratoconus that preserves the ...
According to Chang, these findings suggest that “OTX-TKI has more widespread effects on overall retinal leakage and ...
Functional vision improvements are reported, with optimal pupil size considerations for varying light conditions being ...
This case, Singh notes, has profoundly influenced his philosophy of glaucoma management: balancing surgical risk with the ...
Luis Arias, MD; and Paolo Lanzetta, MD, recently found themselves on opposite sides of the debate table regarding the value ...
Stoke Therapeutics announced 2-year data from the FALCON study, a prospective natural history study in people with autosomal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results